Outbreak of <i>Streptococcus pyogenes emm89</i> ST646 in a head and neck surgical oncology ward
Brian Hayama(Japanese Foundation For Cancer Research), Daisuke Ohkushi(Japanese Foundation For Cancer Research), Kazumi Takehana(Japanese Foundation For Cancer Research), Taisuke Enokida(Japanese Foundation For Cancer Research), Yusuke Nomura(University of Tokyo Hospital), Masahiro Suzuki(Fujita Health University), Kotaro Aoki(Toho University), Sohei Harada(University of Tokyo Hospital), Tomomi Akatsuchi(Japanese Foundation For Cancer Research), Akira Seto(Japanese Foundation For Cancer Research), Koichi Takeda(Japanese Foundation For Cancer Research), Hiroki Mitani(Japanese Foundation For Cancer Research), Yohei Doi(Fujita Health University)
Cited by 4
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by<i>Enterobacter</i>,<i>Citrobacter</i>or<i>Serratia</i>species: a systematic review with meta-analysis
|Journal of Antimicrobial Chemotherapy|2015|86
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
|Clinical Microbiology and Infection|2016|83